TRCT
VNRX icon

Tower Research Capital (TRC)’s VolitionRx Ltd VNRX Stock Holding History

Tower Research Capital (TRC)’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.79K Buy
5,768
+3,952
+218% +$9.53K ﹤0.01% 4112
2026
Q1 		$7.34K Buy
1,816
+1,018
+128% +$4.86K ﹤0.01% 4011
2025
Q4 		$4.08K Buy
798
+578
+263% +$4.39K ﹤0.01% 4261
2025
Q3 		$2.99K Sell
220
-44
-17% -$586 ﹤0.01% 4559
2025
Q2 		$4.02K Sell
264
-369
-58% -$4.07K ﹤0.01% 4393
2025
Q1 		$7.22K Buy
633
+204
+48% +$2.43K ﹤0.01% 3971
2024
Q4 		$5.15K Buy
429
+92
+27% +$1.23K ﹤0.01% 4345
2024
Q3 		$4.05K Sell
337
-388
-54% -$4.99K ﹤0.01% 4695
2024
Q2 		$8.77K Buy
725
+599
+475% +$8.77K ﹤0.01% 4312
2024
Q1 		$1.91K Sell
126
-570
-82% -$11.2K ﹤0.01% 5155
2023
Q4 		$9.97K Buy
696
+294
+73% +$4.32K ﹤0.01% 4315
2023
Q3 		$5.53K Sell
402
-206
-34% -$5.09K ﹤0.01% 4706
2023
Q2 		$16.9K Buy
608
+296
+95% +$9.74K ﹤0.01% 3538
2023
Q1 		$12K Buy
312
+63
+25% +$2.64K ﹤0.01% 4131
2022
Q4 		$12K Sell
249
-534
-68% -$20.7K ﹤0.01% 3760
2022
Q3 		$21K Buy
783
+440
+128% +$16.6K ﹤0.01% 3908
2022
Q2 		$14K Buy
343
+195
+132% +$9.82K ﹤0.01% 4172
2022
Q1 		$9K Sell
148
-50
-25% -$2.83K ﹤0.01% 4502
2021
Q4 		$12K Buy
198
+193
+3,860% +$13.2K ﹤0.01% 4330
2021
Q3 		$0 Sell
5
-196
-98% -$12.4K ﹤0.01% 6211
2021
Q2 		$13K Sell
201
-674
-77% -$45.6K ﹤0.01% 4244
2021
Q1 		$66K Buy
875
+656
+300% +$56.3K ﹤0.01% 2899
2020
Q4 		$17K Sell
219
-954
-81% -$65.7K ﹤0.01% 3983
2020
Q3 		$75K Buy
1,173
+1,115
+1,922% +$75.8K ﹤0.01% 3355
2020
Q2 		$5K Buy
+58
New +$4.19K ﹤0.01% 4302
2020
Q1 		– Sell
-30
Closed -$3K – 3963
2019
Q4 		$3K Sell
30
-6
-17% -$622 ﹤0.01% 2974
2019
Q3 		$4K Sell
36
-4
-10% -$318 ﹤0.01% 3468
2019
Q2 		$3K Buy
+40
New +$2.59K ﹤0.01% 3172
2019
Q1 		– Sell
-89
Closed -$3K – 4318
2018
Q4 		$3K Buy
89
+81
+1,013% +$3.85K ﹤0.01% 3227
2018
Q3 		$0 Sell
8
-188
-96% -$7.73K ﹤0.01% 4280
2018
Q2 		$8K Buy
196
+166
+553% +$7.42K ﹤0.01% 2899
2018
Q1 		$1K Buy
+30
New +$1.75K ﹤0.01% 3105
2017
Q4 		– Sell
-342
Closed -$18K – 4060
2017
Q3 		$18K Buy
342
+281
+461% +$16.5K ﹤0.01% 2797
2017
Q2 		$4K Buy
61
+36
+144% +$2.6K ﹤0.01% 2127
2017
Q1 		$2K Buy
+25
New +$2.21K ﹤0.01% 2671
2016
Q3 		– Sell
-33
Closed -$2K – 4504
2016
Q2 		$2K Buy
33
+23
+230% +$1.59K ﹤0.01% 3973
2016
Q1 		$1K Buy
+10
New +$751 ﹤0.01% 3805
2015
Q4 		– Sell
-1
Closed – – 5094
2015
Q3 		$0 Sell
1
-2
-67% -$154 ﹤0.01% 4830
2015
Q2 		$0 Sell
3
-2
-40% -$151 ﹤0.01% 5074
2015
Q1 		$0 Buy
+5
New +$414 ﹤0.01% 4974

Other funds holding VNRX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WANY
Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Tower Research Capital (TRC)'s VNRX Position: Q2 2026 in Review

Tower Research Capital (TRC) increased its VolitionRx Ltd (VNRX) stake by 218% in Q2 2026, buying an estimated $9.53K and bringing the position to 5,768 shares worth $7.79K. The position accounts for ﹤0.01% of the portfolio, ranked #4112.

Tower Research Capital (TRC) first reported a position in VNRX in Q1 2015 and has held it in 40 quarters since. The position peaked at $75K in Q3 2020. 19 funds tracked by Wall St. Rank hold VNRX as of Q2 2026.

  • Tower Research Capital (TRC) held 5,768 shares of VolitionRx Ltd worth $7.79K as of Q2 2026.
  • Tower Research Capital (TRC) bought 3,952 VolitionRx Ltd shares in Q2 2026, an estimated $9.53K.
  • VolitionRx Ltd made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4112 holding.
  • Tower Research Capital (TRC) first reported a position in VolitionRx Ltd in Q1 2015 and has held it in 40 quarters since.
  • Tower Research Capital (TRC)'s VolitionRx Ltd position peaked at $75K in Q3 2020.
  • 19 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.